Competition law and the pharma sector: access to (expensive) medicines on the European and national agenda

Dutch government to take action against expensive medicines, competition authorities target pharmaceutical companies, and NZa provides more clarity on add-on medicines. Read more >

Amendment to Prices Act: ACM targets price reduction campaigns

ACM tightens enforcement of new price reduction rules: some practical tips. Read more >

Publisher not obligated to extend collaboration with Blendle

The Amsterdam Court has ruled in preliminary relief proceedings that the licence agreement between Blendle and a publisher need not be extended. No abuse of a dominant position by the publisher is involved. Read more >

Five tips for tendering in the social domain: how can a care provider achieve realistic rates?

Care providers regularly have to deal with low or inadequate rates that municipalities apply to their social support care or youth care. Litigation may then be the appropriate response. Some practical tips are provided in this blog. Read more >

Duty of care/procurement duty, waiting lists and catch-up care: the enforcement ball is in the NZa’s court

The end of the corona pandemic is in sight. Many insured are waiting for post-COVID catch-up care. Our latest blog explains how the NZa is taking action to curb these consequences of the corona crisis. Read more >

Dispute between radiologists settled on the basis of cartel prohibition: breach of non-compete clause not a valid ground for termination within a cooperative

Court of Appeal rules in dispute between radiologists that termination of membership of cooperative on the grounds of breach of non-compete clause is invalid, because the clause is contrary to the cartel prohibition. Read more >

Will the new NZa healthcare procurement regulations lead to effective supervision of health insurers?

This blog addresses the new version of the NZa Healthcare Procurement Regulations and the NZa’s role in their enforcement. Read more >

Autumn trends for 2023
Read more >


Please register here for our newsletter.